n18

Better R&D income led to jump in profits: Dishman Pharma

last updated on February 09, 2012 at 5:20 pm moneycontrol

Managing director of Dishman Pharma tells CNBC-TV18 that higher earnings from its contract revenue business is what led to the surge in third quarter profits.

Tags : # #

YOU MAY LIKE


04:29 26 May 2012 from Tech2

Creative Sound Blaster Recon3D Fatal1ty Champion Review

Back in the day, when audio solutions weren’t integrated into motherboards, people had to go out and buy their own sound cards. They were large, sophisticated pieces of hardware. Creative is one of the oldest companies known to...

04:19 26 May 2012 from FirstPost

How to deal with your home loan better

If you have taken a home loan of Rs 50 lakh, have a period of 10 years to repay it and the interest rate is 10 percent, the interest amount you end up paying is around Rs 66 lakh. That's the estimate that Hindustan Times reports for an average home...

03:09 26 May 2012 from Moneycontrol

Jet Air wants to boost income via ancillary activities

Moneycontrol Bureau  After posting a fifth straight quarterly loss in the Jan-March quarter, Jet Airways is trying hard to prune its operating costs and improve sales. This, the airline believes can be achieved by cutting down loss-making...

N18 Msg